Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000009

CEO bought 38,000 shares at an average $0.03 ($985)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-06 Purchase : show line 1 in the form +5,000 $0.03 $133 21,098,623 D
2019-02-06 Purchase : show line 2 in the form +5,000 $0.03 $130 21,103,623 D
2019-02-06 Purchase : show line 3 in the form +5,000 $0.03 $130 21,108,623 D
2019-02-07 Purchase : show line 4 in the form +1,000 $0.03 $26 21,109,623 D
2019-02-07 Purchase : show line 5 in the form +5,000 $0.03 $129 21,114,623 D
2019-02-07 Purchase : show line 6 in the form +10,000 $0.03 $257 21,124,623 D
2019-02-07 Purchase : show line 7 in the form +5,000 $0.03 $129 21,129,623 D
2019-02-07 Purchase : show line 8 in the form +1,000 $0.03 $26 21,130,623 D
2019-02-07 Purchase : show line 9 in the form +1,000 $0.03 $26 21,131,623 D
Open-market purchases · 38,000 sh · avg $0.03 · $985
Loading xslF345X03/primary_doc.xml…